State of Louisiana, by & through its Attorney General, Liz Murrill; Rosalie Markezich v. Food & Drug Administration; Marty Makary; Richard Pazdur
The Fifth Circuit granted Louisiana's motion to stay the FDA's 2023 regulation allowing remote dispensing of mifepristone. The court held that the agency's admission of failing to study remote dispensing safety created irreparable harm that outweighed the public interest in maintaining the rule.